For informational purposes only — not investment advice

← Back to signals

ATRA

Atara Biotherapeutics, Inc.

Research: Finviz ↗·Perplexity ↗

No convergence signal this quarter — shown because tracked funds have filed 13D/G on this stock.

Days to cover (short int.)
13.4d↓-7.8%
as of 2026-10-30 · shares short vs 2026-09-30

Fund 13D/13G Filings (2)

Tracked funds' beneficial-ownership filings on this stock — disclosed within days of a position change, fresher than the quarterly 13F. Since Filing compares the stock to SPY from the filing date (shown for filings within the last 90 days).

FundForm∆ Shares% of ClassSince FilingFiledSrc
Point72SC 13G/A+161K7.6%
+0.3% vs SPY
-2.0% abs
2026-08-14↗
Point72SC 13GNEW6.2%
-5.5% vs SPY
-1.1% abs
2026-05-08↗
ATRA Hedge Fund Ownership — 13F Research